Dreker T - Search Results

1

Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro.

Jäger H, Dreker T, Buck A, Giehl K, Gress T, Grissmer S. Jäger H, et al. Among authors: dreker t. Mol Pharmacol. 2004 Mar;65(3):630-8. doi: 10.1124/mol.65.3.630. Mol Pharmacol. 2004. PMID: 14978241

2

Investigation of the phenylalkylamine binding site in hKv1.3 (H399T), a mutant with a reduced C-type inactivated state.

Dreker T, Grissmer S. Dreker T, et al. Mol Pharmacol. 2005 Oct;68(4):966-73. doi: 10.1124/mol.105.012401. Epub 2005 Jul 6. Mol Pharmacol. 2005. PMID: 16000530

3

A novel non-neuronal hSK3 isoform with a dominant-negative effect on hSK3 currents.

Wittekindt OH, Dreker T, Morris-Rosendahl DJ, Lehmann-Horn F, Grissmer S. Wittekindt OH, et al. Among authors: dreker t. Cell Physiol Biochem. 2004;14(1-2):23-30. doi: 10.1159/000076923. Cell Physiol Biochem. 2004. PMID: 14976403

4

Why does the inner-helix mutation A413C double the stoichiometry of Kv1.3 channel block by emopamil but not by verapamil?

Rossokhin A, Dreker T, Grissmer S, Zhorov BS. Rossokhin A, et al. Among authors: dreker t. Mol Pharmacol. 2011 Apr;79(4):681-91. doi: 10.1124/mol.110.068031. Epub 2011 Jan 10. Mol Pharmacol. 2011. PMID: 21220411

5

Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants.

Pegoraro S, Lang M, Dreker T, Kraus J, Hamm S, Meere C, Feurle J, Tasler S, Prütting S, Kuras Z, Visan V, Grissmer S. Pegoraro S, et al. Among authors: dreker t. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2299-304. doi: 10.1016/j.bmcl.2009.02.077. Epub 2009 Feb 25. Bioorg Med Chem Lett. 2009. PMID: 19282171

6

Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME).

Bretz AC, Parnitzke U, Kronthaler K, Dreker T, Bartz R, Hermann F, Ammendola A, Wulff T, Hamm S. Bretz AC, et al. Among authors: dreker t. J Immunother Cancer. 2019 Nov 8;7(1):294. doi: 10.1186/s40425-019-0745-3. J Immunother Cancer. 2019. PMID: 31703604 Free PMC article.

7

Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.

Bozdag M, Dreker T, Henry C, Tosco P, Vallaro M, Fruttero R, Scozzafava A, Carta F, Supuran CT. Bozdag M, et al. Among authors: dreker t. Bioorg Med Chem Lett. 2013 Feb 1;23(3):715-9. doi: 10.1016/j.bmcl.2012.11.102. Epub 2012 Dec 2. Bioorg Med Chem Lett. 2013. PMID: 23265898 Free article.

8

Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors.

Trabocchi A, Pala N, Krimmelbein I, Menchi G, Guarna A, Sechi M, Dreker T, Scozzafava A, Supuran CT, Carta F. Trabocchi A, et al. Among authors: dreker t. J Enzyme Inhib Med Chem. 2015 Jun;30(3):466-71. doi: 10.3109/14756366.2014.947976. Epub 2014 Sep 8. J Enzyme Inhib Med Chem. 2015. PMID: 25198885 Free article.

9

Corrigendum: Epigenetics and Metabolism in Health and Disease.

Tzika E, Dreker T, Imhof A. Tzika E, et al. Among authors: dreker t. Front Genet. 2020 Apr 23;11:428. doi: 10.3389/fgene.2020.00428. eCollection 2020. Front Genet. 2020. PMID: 32391064 Free PMC article.

10

Epigenetics and Metabolism in Health and Disease.

Tzika E, Dreker T, Imhof A. Tzika E, et al. Among authors: dreker t. Front Genet. 2018 Sep 18;9:361. doi: 10.3389/fgene.2018.00361. eCollection 2018. Front Genet. 2018. PMID: 30279699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters